Key points to consider when interpreting the evidence: Most studies are short-term , typically lasting fewer than 12 weeks, making it difficult to assess long-term efficacy or safety Results appear more pronounced in older adults or individuals with obesity, compared to younger, healthy populations L-carnitine alone, without dietary or lifestyle changes , is unlikely to produce clinically meaningful weight loss Neither NICE nor the NHS recommends L-carnitine supplementation as part of any weight management pathway
The medication should typically be just one part of an individuals weight-management plan
Further, this data suggests that rather than buffering oxidative stress to prevent liver damage, GSH synthesis is crucial for maintaining low NRF2 levels and sustaining lipid production by the liver
Robyn Gmyrek is a board-certified dermatologist at UnionDerm in New York City who has received national recognition for her contributions to cosmetic dermatology, including Castle and Connolly Americas Top Doctors, New York Magazines 2013-2020 Best Doctors, and inclusion in the 2013-2020 lists of Super Doctors
Cardiovascular effects of glucagon-like peptide 1 receptor agonists: From mechanistic studies in humans to clinical outcomes
Those with suspected fatty liver: The liver-supporting MIC combination may help improve hepatic function
